AKT1 and neoplasm: Notably, recent studies suggest that increased activation of the PI3K-AKT pathway in brain metastases compared to patient-matched primary tumors and extracranial metastases is observed in many different tumor types, further supporting the rationale for therapeutic development and clinical trials in this area.17,57